HemaSphere (Oct 2022)

T002: Treatment related morbidity in patients with classical Hodgkin Lymphoma: results of the ongoing, randomized phase III HD21 Trial by The German Hodgkin Study Group

  • Peter Borchmann,
  • Alden Moccia,
  • Richard Greil,
  • Mark Herzberg,
  • Alexander Fosså,
  • Andreas Hüttmann,
  • Felix Keil,
  • Judith Dierlamm,
  • Valdete Schaub,
  • Mathias Hänel,
  • Urban Novak,
  • Julia Meissner,
  • Johannes Hellmuth,
  • Stephan Mathas,
  • Josée. M. Zijlstra,
  • Andreas Viardot,
  • Bernd Hertenstein,
  • Sonja Martin,
  • Pratush Giri,
  • Stefanie Kreissl,
  • Michael Fuchs,
  • Gundolf Schneider,
  • Andreas Rosenwald,
  • Wolfram Klapper,
  • Hans Theodor Eich,
  • Christian Baues,
  • Michael Hallek,
  • Carsten Kobe,
  • Volker Diehl,
  • Andreas Engert

DOI
https://doi.org/10.1097/01.HS9.0000890576.23258.1c
Journal volume & issue
Vol. 6
pp. 1 – 2

Abstract

Read online

No abstracts available.